Cargando…

351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)

BACKGROUND: Chronic autoimmune thyroiditis, manifested by positive test for antithyroid antibodies, is common in the general population, occurring in 10 to 20 percent of women. The aim of the study was to determine whether Anti-TPO is more prevalent in women with ACTD, compared to the general popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadopoulos, Georgios, Vakaloudi, Anastasia, Koutsika, Eirene, Anastasiou, Ekarerini, Koteli, Asimoula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512836/
http://dx.doi.org/10.1097/01.WOX.0000412114.72909.6f
_version_ 1782251813511102464
author Papadopoulos, Georgios
Vakaloudi, Anastasia
Koutsika, Eirene
Anastasiou, Ekarerini
Koteli, Asimoula
author_facet Papadopoulos, Georgios
Vakaloudi, Anastasia
Koutsika, Eirene
Anastasiou, Ekarerini
Koteli, Asimoula
author_sort Papadopoulos, Georgios
collection PubMed
description BACKGROUND: Chronic autoimmune thyroiditis, manifested by positive test for antithyroid antibodies, is common in the general population, occurring in 10 to 20 percent of women. The aim of the study was to determine whether Anti-TPO is more prevalent in women with ACTD, compared to the general population. METHODS: Anti-TPO was determined in 290 women diagnosed with ACTD based on ACR (American College of Rheumatology) criteria and in 50 healthy women (control group). Among ACTD patients, 121 were diagnosed with Rheumatoid Arthritis (RA), 44 Systemic Lupus Erythematosus (SLE), 43 Sjοgren's Syndrome (SS), 42 Systemic Scleroderma (SScl) and 40 Psoriatic Arthritis (PsA). Anti-TPO was measured by Chemiluminescent Microparticle Immunoassay (CMIA) on Architect i2000SR (ABBOT Laboratories). RESULTS: The prevalence of Anti-TPO in separate groups of patients had as follow: RA 28.93%, SLE 29.55%, SS 27.91%, SScl 23.81%, PsA 30% and control group 12%. CONCLUSIONS: ACTD and thyroid autoimmune diseases often overlap with each other. Increased Anti-TPO may be most common among women patients with ACTD. On the other hand, these systemic diseases are often present in Hasimoto's thyroiditis subjects. Therefore it is clinically important to screen women patients with ACTD for the co-existence of thyroid disorders.
format Online
Article
Text
id pubmed-3512836
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35128362012-12-21 351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD) Papadopoulos, Georgios Vakaloudi, Anastasia Koutsika, Eirene Anastasiou, Ekarerini Koteli, Asimoula World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Chronic autoimmune thyroiditis, manifested by positive test for antithyroid antibodies, is common in the general population, occurring in 10 to 20 percent of women. The aim of the study was to determine whether Anti-TPO is more prevalent in women with ACTD, compared to the general population. METHODS: Anti-TPO was determined in 290 women diagnosed with ACTD based on ACR (American College of Rheumatology) criteria and in 50 healthy women (control group). Among ACTD patients, 121 were diagnosed with Rheumatoid Arthritis (RA), 44 Systemic Lupus Erythematosus (SLE), 43 Sjοgren's Syndrome (SS), 42 Systemic Scleroderma (SScl) and 40 Psoriatic Arthritis (PsA). Anti-TPO was measured by Chemiluminescent Microparticle Immunoassay (CMIA) on Architect i2000SR (ABBOT Laboratories). RESULTS: The prevalence of Anti-TPO in separate groups of patients had as follow: RA 28.93%, SLE 29.55%, SS 27.91%, SScl 23.81%, PsA 30% and control group 12%. CONCLUSIONS: ACTD and thyroid autoimmune diseases often overlap with each other. Increased Anti-TPO may be most common among women patients with ACTD. On the other hand, these systemic diseases are often present in Hasimoto's thyroiditis subjects. Therefore it is clinically important to screen women patients with ACTD for the co-existence of thyroid disorders. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512836/ http://dx.doi.org/10.1097/01.WOX.0000412114.72909.6f Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Papadopoulos, Georgios
Vakaloudi, Anastasia
Koutsika, Eirene
Anastasiou, Ekarerini
Koteli, Asimoula
351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
title 351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
title_full 351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
title_fullStr 351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
title_full_unstemmed 351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
title_short 351 Prevalence of Thyroid Peroxidase Autoantibodies (ANTI-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD)
title_sort 351 prevalence of thyroid peroxidase autoantibodies (anti-tpo) in women with autoimmune connective tissue diseases (actd)
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512836/
http://dx.doi.org/10.1097/01.WOX.0000412114.72909.6f
work_keys_str_mv AT papadopoulosgeorgios 351prevalenceofthyroidperoxidaseautoantibodiesantitpoinwomenwithautoimmuneconnectivetissuediseasesactd
AT vakaloudianastasia 351prevalenceofthyroidperoxidaseautoantibodiesantitpoinwomenwithautoimmuneconnectivetissuediseasesactd
AT koutsikaeirene 351prevalenceofthyroidperoxidaseautoantibodiesantitpoinwomenwithautoimmuneconnectivetissuediseasesactd
AT anastasiouekarerini 351prevalenceofthyroidperoxidaseautoantibodiesantitpoinwomenwithautoimmuneconnectivetissuediseasesactd
AT koteliasimoula 351prevalenceofthyroidperoxidaseautoantibodiesantitpoinwomenwithautoimmuneconnectivetissuediseasesactd